CanadaSemaglutide Injection by Dr. Reddy’s Laboratories Canada Inc., labelled as 2 mg/pen (DIN 02567806), strength 1.34 mg/ml, lot 7000544C, is affected because the package contains a 4 mg pen but is labelled as a 2 mg pen. Owners should verify if their product is affected; consult their healthcare provider before discontinuing use or for health concerns; contact the recalling firm with questions; and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of Recall: Retaillers
Companies: Recalling firm: Dr. Reddy's Laboratories Canada Inc., 5580 Explorer Dr, Suite 204, Mississauga,ON L4W 4Y1, Market Authorization Holder, DR REDDY'S LABORATORIES LTD, Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally, Medchal-Malkajgiri, Telangana, India 500090.
How to identify it
Brand: Dr. Reddy's Laboratories Canada Inc.; Product Name: Semaglutide Injection (labelled as 2mg/pen); Market Authorization: DIN 02567806; Dosage Form: Solution; Strength: 1.34 mg/ml; Lot Number: 7000544C
The hazard
The affected lot contains a 4 mg pen but is labelled as a 2 mg pen.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)